[Evaluation of econazol in 594 cases of skin mycosis (author's transl)].
A total of 594 patients were treated with the new antimycotic agent econazol (Pevaryl). The diagnosis was proven microscopically and on culture except in cases of pityriasis versicolor where it was proven microscopically only. Econazol was given to 130 patients as a 1% solution, to 128 patients as a 1% milk, and to 336 patients as a 1% spray solution. In 333 cases of foot mycosis or eczema marginatum econazol spray powder was given in addition. As measured by the cure rate the spray solution (92%) was not significantly more effective than the milk (89%) or the simple solution (87%). Criteria for cure included negative microscopy and fungal cultures a week after treatment had ceased as well as clinical cure. A total of 90% of all cases (n = 536) could be considered as cured microscopically and on culture after an average of 3.6 weeks (pityriasis versicolor) and 4.8 weeks (tinea pedis, manus, inguinocruralis). In a further 4.4% (n = 26) the fungus could be demonstrated microscopically despite a clinical cure and in 7 of these cases culture was also positive. The cure rate was independent of the responsible pathogen. The preparations were tolerated extremely well. In 7 cases, however, transient dermatitic irritations were seen in the inguinocrural region, mainly caused by the simple solution.
D000336:Aerosols; D055598:Chemical Phenomena; D002621:Chemistry; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy*; D004821:Epidermophyton; D005260:Female; D006229:Hand Dermatoses / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D014009:Onychomycosis / Q000188:drug therapy; D012996:Solutions; D014005:Tinea / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy; D014010:Tinea Versicolor / Q000188:drug therapy; D014249:Trichophyton
D000336:Aerosols; D002722:Chlorobenzenes; D007093:Imidazoles; D012996:Solutions
Poliklinische Prüfung von Econazol bei 594 Fällen von Hautmykosen